Gadobenate dimeglumine (Gd-BOPTA). An overview.
Kirchin
M A
MA
Bracco SpA, Milan, Italy.
Pirovano
G P
GP
Spinazzi
A
A
D000818:Animals; D002493:Central Nervous System Diseases / Q000175:diagnosis; D003287:Contrast Media / Q000009:adverse effects / Q000493:pharmacokinetics; D005682:Gadolinium; D006331:Heart Diseases / Q000175:diagnosis; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis; D018810:Magnetic Resonance Angiography; D008536:Meglumine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D009942:Organometallic Compounds / Q000009:adverse effects / Q000493:pharmacokinetics
D003287:Contrast Media; D009942:Organometallic Compounds; C064572:gadobenic acid; D008536:Meglumine; D005682:Gadolinium